Synapse

← Biomarkers in Cancer

Papers in Biomarkers in Cancer

Page 1 · newest first

  1. Chemotherapy Resistance in Advanced Ovarian Cancer PatientsBiomarkers in Cancer · 2019
  2. Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and ImmunohistochemistryBiomarkers in Cancer · 2019
  3. Urine Biomarkers for the Early Detection of Ovarian Cancer – Are We There Yet?Biomarkers in Cancer · 2019
  4. Detection of Micro-invasion in Sudanese Oral Verrucous Carcinoma Samples Using Syndecan-1 StainBiomarkers in Cancer · 2019
  5. RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant ProgressionBiomarkers in Cancer · 2019
  6. Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder CancerBiomarkers in Cancer · 2019
  7. Following Chemotherapy: Serum Cytokine (Tumor Necrosis Factor, Interleukin-2, Interleukin-11), Immunoglobulin, Complement, Vascular Endothelial Growth Factor Levels, and the Systemic Symptoms like Capillary Leak SyndromeBiomarkers in Cancer · 2019
  8. Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers?Biomarkers in Cancer · 2018
  9. A Combinatorial Proteomic Biomarker Assay to Detect Ovarian Cancer in WomenBiomarkers in Cancer · 2018
  10. Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung CancerBiomarkers in Cancer · 2018
  11. Data Mining of Small RNA-Seq Suggests an Association Between Prostate Cancer and Altered Abundance of 5′ Transfer RNA Halves in Seminal Fluid and Prostatic TissuesBiomarkers in Cancer · 2018
  12. Vasodilator-Stimulated Phosphoprotein Biomarkers Are Associated with Invasion and Metastasis in Colorectal CancerBiomarkers in Cancer · 2018
  13. HumanMethylation450K Array–Identified Biomarkers Predict Tumour Recurrence/Progression at Initial Diagnosis of High-risk Non-muscle Invasive Bladder CancerBiomarkers in Cancer · 2018
  14. More Accurate Oral Cancer Screening with Fewer Salivary BiomarkersBiomarkers in Cancer · 2017
  15. Biomarkers for Hepatocellular CarcinomaBiomarkers in Cancer · 2017
  16. Preoperative Serum Carcinoembryonic Antigen as a Marker for Predicting the Outcome of Three CancersBiomarkers in Cancer · 2017
  17. miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell CarcinomaBiomarkers in Cancer · 2017
  18. Long Noncoding RNAs as a Key Player in Hepatocellular CarcinomaBiomarkers in Cancer · 2017
  19. Analysis of Fascin-1 in Relation to Gleason Risk Classification and Nuclear ETS-Related Gene Status of Human Prostate Carcinomas: An Immunohistochemical Study of Clinically Annotated Tumours From the Wales Cancer BankBiomarkers in Cancer · 2017
  20. In Search for Optimal Targets for Intraoperative Fluorescence Imaging of Peritoneal Metastasis From Colorectal CancerBiomarkers in Cancer · 2017
  21. Predicting Clinical Outcomes Using Molecular BiomarkersSHILAP Revista de lepidopterología · 2016
  22. BMI1: A Biomarker of Hematologic MalignanciesBiomarkers in Cancer · 2016
  23. Impact of Concanavalin-A-Mediated Cytoskeleton Disruption on Low-Density Lipoprotein Receptor-Related Protein-1 Internalization and Cell Surface Expression in GlioblastomasBiomarkers in Cancer · 2016
  24. The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsBiomarkers in Cancer · 2016
  25. Targeted Radionuclide Therapy: Practical Applications and Future ProspectsBiomarkers in Cancer · 2016
  26. Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR ImagesBiomarkers in Cancer · 2016
  27. Circulating Neutrophil MicroRNAs as Biomarkers for the Detection of Lung CancerBiomarkers in Cancer · 2016
  28. The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer TherapyBiomarkers in Cancer · 2016
  29. Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaBiomarkers in Cancer · 2016
  30. Imaging Biomarkers in ImmunotherapyBiomarkers in Cancer · 2016
  31. Novel Molecular Markers for Breast CancerBiomarkers in Cancer · 2016
  32. Role of Biomarkers in the Development of PARP InhibitorsBiomarkers in Cancer · 2016
  33. Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and PaclitaxelBiomarkers in Cancer · 2016
  34. The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer MedicineBiomarkers in Cancer · 2016
  35. Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other CancersBiomarkers in Cancer · 2016
  36. Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsBiomarkers in Cancer · 2016
  37. PET Metabolic Biomarkers for CancerBiomarkers in Cancer · 2016
  38. Oncogenes: The Passport for Viral Oncolysis through PKR InhibitionBiomarkers in Cancer · 2016
  39. Association of MTHFR (C677T) Gene Polymorphism with Breast Cancer in North IndiaBiomarkers in Cancer · 2016
  40. Biomarkers and Targeted Therapy in Pancreatic CancerBiomarkers in Cancer · 2016
  41. Interleukin 1β—A Potential Salivary Biomarker for Cancer Progression?SHILAP Revista de lepidopterología · 2015
  42. CD151—A Striking Marker for Cancer TherapyBiomarkers in Cancer · 2015
  43. Ameloblastoma: A Review of Recent Molecular Pathogenetic DiscoveriesBiomarkers in Cancer · 2015
  44. Human Cancer Immunotherapy with PD-1/PD-L1 BlockadeBiomarkers in Cancer · 2015
  45. Gastrointestinal Stromal Tumors (GIST): A Prospective Analysis and an Update on Biomarkers and Current Treatment ConceptsBiomarkers in Cancer · 2015
  46. Tritsomy 8 Acute Myeloid Leukemia Analysis Reveals New Insights of DNA Methylome with Identification ofHHEXas Potential Diagnostic MarkerBiomarkers in Cancer · 2015
  47. Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast CancerBiomarkers in Cancer · 2015
  48. BRAF Mutation in Colorectal Cancer: An UpdateBiomarkers in Cancer · 2015
  49. Biomarkers of Angiogenesis in Colorectal CancerBiomarkers in Cancer · 2015
  50. Microparticles as Biomarkers of Blood Coagulation in CancerBiomarkers in Cancer · 2015